SCHEMBL869709

SCHEMBL869709

CC(C)c1ccc(CCC=O)cc1.CC(C)c1ccc(CCC=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.48
IDO1 P14902 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 2/20 0.41
FKBP1A P62942 1/20 0.41
RAB9A P51151 4/20 0.39
USP5 P45974 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
POLB P06746 1/20 0.38
EPHX1 P07099 1/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
MAPT P10636 1/20 0.37
PYCR1 P32322 1/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL933030 1.00 TYR (0.48) TYRIDO1L3MBTL1ALDH1A1FKBP1A
Propionaldehyde SCHEMBL4619414 0.94 TYR (0.44) TYRIDO1L3MBTL1ALDH1A1FKBP1A
SCHEMBL3249124 0.88 TYR (0.45) TYRIDO1L3MBTL1ALDH1A1FKBP1A
SCHEMBL3205913 0.86 TYR (0.44) TYRIDO1L3MBTL1ALDH1A1FKBP1A
SCHEMBL7549361 0.84 TYR (0.32) TYRL3MBTL1ALDH1A1EPHX1LMNA
SCHEMBL13767934 0.84 TYR (0.32) TYRL3MBTL1ALDH1A1EPHX1LMNA
Cuminaldehyde SCHEMBL9297326 0.83 TYR (0.59) TYRL3MBTL1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL18989344 0.83 ALDH1A1 (0.41) TYRL3MBTL1ALDH1A1FKBP1ARAB9A
SCHEMBL9671868 0.82 HIF1A (0.37) ALDH1A1LMNA
SCHEMBL22125055 0.81 SLC6A2 (0.41) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3389733-A1 COMPOSITIONS, DELIVERY SYSTEMS AND REFILLS FOR EMITTING TWO OR MORE COMPOSITIONS S.C. Johnson & Son, Inc. (US) 2018-10-24 EP disclosed
US-9855361-B2 Compositions, delivery systems and refills for emitting two or more compositions S. C. JOHNSON & SON, INC. (US) 2018-01-02 US disclosed
EP-2221039-B1 Antiperspirant compositions UNILEVER PLC NO 41424 (GB) 2017-11-22 EP disclosed
WO-2017105725-A1 COMPOSITIONS, DELIVERY SYSTEMS AND REFILLS FOR EMITTING TWO OR MORE COMPOSITIONS S. C. JOHNSON & SON, INC. (US) 2017-06-22 WO disclosed
US-20170165391-A1 COMPOSITIONS, DELIVERY SYSTEMS AND REFILLS FOR EMITTING TWO OR MORE COMPOSITIONS S. C. JOHNSON & SON, INC. (US) 2017-06-15 US disclosed
EP-2181691-B1 Antiperspirant compositions UNILEVER PLC (GB) 2016-12-21 EP disclosed
EP-2179719-B1 Antiperspirant or deodorant compositions UNILEVER PLC (GB) 2016-10-12 EP disclosed
EP-2181692-B1 Antiperspirant compositions UNILEVER PLC (GB) 2016-09-28 EP disclosed
US-20120076839-A1 ANTIPERSPIRANT COMPOSITIONS CONOPCO, INC., D/B/A UNILEVER 2012-03-29 US disclosed
WO-2010094546-A2 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2010-08-26 WO disclosed
EP-2221039-A1 Antiperspirant compositions Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House (GB) 2010-08-25 EP disclosed
EP-2181692-A1 Antiperspirant compositions Unilever PLC (GB) 2010-05-05 EP disclosed
EP-2181691-A1 Antiperspirant compositions Unilever PLC (GB) 2010-05-05 EP disclosed
EP-2179719-A1 Antiperspirant or deodorant compositions Unilever PLC (GB) 2010-04-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120076839-A1 ANTIPERSPIRANT COMPOSITIONS HNMT, HRH2, HTR2A TYR 177/4885IDO1 611/4885L3MBTL1 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.